Long COVID: The Impact of Post-Acute Sequelae of COVID-19 (PASC)
November 12, 2021 There is mounting evidence of the importance and seriousness of the long-term effects of COVID-19. Post-acute sequelae of SARS-CoV-2 (PASC, or “long COVID”) is characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms (1). Approximately 80% of individuals with a confirmed COVID-19 diagnosis continue to…
GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges
GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges Thursday, December 02, 2021 – Friday, December 03, 2021 Towards the deployment of a global and collaborative diagnostic arsenal to detect and fight against pandemics The current COVID-19 pandemic has again emphasized the importance of accurate, rapid, and massively deployed diagnostics to effectively contain viral transmission.…
New Antivirals: Could They Be Game Changers?
November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future, prevent infection after contamination. It is likely…
SARS-CoV-2, Children, and Multi-Inflammatory Syndrome
October 1, 2021 With the advent of the school year and children returning to in-person classes, there comes a concern over consequences with respect to the spread of the highly contagious Delta variant. It has been accepted that children are not as susceptible to viral infection and severe illness as adults. However, the current prevalence…
Covid-19 Vaccines or Natural Immunity – Do Both Protect?
Covid-19 Vaccines or Natural Immunity – Do Both Protect? September 10, 2021 In the current circumstances of disturbingly high rates of infection by the Delta variant and the concerns over obtaining effective vaccine coverage, the degree of protection provided to SARS-CoV-2 infected convalescent people is of clear relevance for natural immunity. Pei et al. estimate…
Vaccines and Variants
Vaccines and Variants August 16, 2021 Extensive vaccination had resulted in reduced COVID-19 cases and mortality in certain places, such as the United States and Israel, thus giving a cautious optimism that the worst of the pandemic was over. However, this turned out not to be the case, due to unpredicted factors. One was the…
Global Virus Network Recommends Moving Forward With Boosters for COVID-19 Response
Fragile populations should receive a booster third dose of the COVID-19 mRNA vaccine to help protect against emerging variants BALTIMORE, MD, August 10, 2021: Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues, today shared that GVN…